AG
REGN icon

AIA Group’s Regeneron Pharmaceuticals REGN Stock Holding History

AIA Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45M Buy
8,736
+276
+3% +$188K 0.07% 148
2026
Q1 		$6.54M Buy
8,460
+1,052
+14% +$805K 0.1% 141
2025
Q4 		$5.72M Sell
7,408
-9,779
-57% -$6.64M 0.09% 150
2025
Q3 		$9.66M Sell
17,187
-70
-0.4% -$39.6K 0.17% 88
2025
Q2 		$9.06M Buy
17,257
+1,164
+7% +$650K 0.2% 65
2025
Q1 		$10.2M Buy
16,093
+2,493
+18% +$1.71M 0.25% 56
2024
Q4 		$9.69M Buy
13,600
+2,959
+28% +$2.48M 0.23% 53
2024
Q3 		$11.2M Buy
10,641
+621
+6% +$691K 0.29% 47
2024
Q2 		$10.5M Buy
10,020
+3,132
+45% +$3.04M 0.31% 43
2024
Q1 		$6.63M Buy
6,888
+2,166
+46% +$2.06M 0.22% 50
2023
Q4 		$4.15M Buy
4,722
+565
+14% +$465K 0.17% 66
2023
Q3 		$3.42M Sell
4,157
-554
-12% -$435K 0.17% 66
2023
Q2 		$3.39M Buy
4,711
+1,077
+30% +$830K 0.16% 71
2023
Q1 		$2.99M Sell
3,634
-2,324
-39% -$1.75M 0.16% 57
2022
Q4 		$4.3M Sell
5,958
-722
-11% -$533K 0.26% 38
2022
Q3 		$4.6M Buy
6,680
+1,601
+32% +$1.01M 0.3% 39
2022
Q2 		$3M Buy
5,079
+1,845
+57% +$1.2M 0.16% 58
2022
Q1 		$2.26M Buy
3,234
+1,439
+80% +$910K 0.1% 94
2021
Q4 		$1.13M Buy
1,795
+696
+63% +$428K 0.05% 132
2021
Q3 		$665K Buy
1,099
+385
+54% +$239K 0.04% 157
2021
Q2 		$418K Sell
714
-804
-53% -$407K 0.03% 152
2021
Q1 		$718K Buy
1,518
+295
+24% +$144K 0.1% 99
2020
Q4 		$601K Buy
+1,223
New +$660K 0.07% 108

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

AIA Group's REGN Position: Q2 2026 in Review

AIA Group increased its Regeneron Pharmaceuticals (REGN) stake by 3.3% in Q2 2026, buying an estimated $188K and bringing the position to 8,736 shares worth $5.45M. The position accounts for 0.07% of the portfolio, ranked #148.

AIA Group first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.2M in Q3 2024. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • AIA Group held 8,736 shares of Regeneron Pharmaceuticals worth $5.45M as of Q2 2026.
  • AIA Group bought 276 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $188K.
  • Regeneron Pharmaceuticals made up 0.07% of AIA Group's portfolio in Q2 2026, its #148 holding.
  • AIA Group first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • AIA Group's Regeneron Pharmaceuticals position peaked at $11.2M in Q3 2024.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.